Insulet earnings were $375.3M for the trailing 12 months ending Jun 30, 2026, with 58.8% growth year over year. The latest PODD earnings report on Jun 30, 2026 announced Q2 2026 earnings of $95.0M, up 4.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PODD reported annual earnings of $247.1M, with -40.9% growth.
PODD past earnings growth
How has PODD's earnings growth performed historically?
On PODD's earnings call on Aug 5, 2026, Insulet (NASDAQ: PODD) reported Q2 2026 earnings per share (EPS) of $1.37, up 328.13% year over year. Total PODD earnings for the quarter were $95.00 million. In the same quarter last year, Insulet's earnings per share (EPS) was $0.32.
As of the last Insulet earnings report, Insulet is currently profitable. Insulet's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $375.30 million, a 58.96% increase year over year.
What was PODD's earnings growth in the past year?
As of Insulet's earnings date in Aug 5, 2026, Insulet's earnings has grown 58.75% year over year. This is 62.36 percentage points higher than the US Medical Devices industry earnings growth rate of -3.61%. PODD earnings in the past year totalled $375.30 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.